Mr. Anil Champalal Jain, from the promoter group, bought 1,00,000 shares of Bajaj Healthcare for ₹3.04 Cr at ₹303.80 apiece through an open market purchase, increasing his stake from 5.75% to 6.05%.
A pharmaceutical manufacturer established in 1993, Bajaj Healthcare produces active pharmaceutical ingredients and formulations for domestic and international markets. The company operates across multiple therapeutic segments, serving hospitals, clinics, and retail pharmacies with a comprehensive product portfolio. Its vertically integrated operations span manufacturing, quality control, and distribution networks across India, supported by research and development capabilities in drug formulation and process optimization.